Net profit of Bafna Pharmaceuticals declined 10.27% to Rs 1.31 crore in the quarter ended March 2025 as against Rs 1.46 crore during the previous quarter ended March 2024. Sales declined 5.65% to Rs 39.06 crore in the quarter ended March 2025 as against Rs 41.40 crore during the previous quarter ended March 2024.
For the full year,net profit declined 43.54% to Rs 4.15 crore in the year ended March 2025 as against Rs 7.35 crore during the previous year ended March 2024. Sales declined 4.34% to Rs 145.86 crore in the year ended March 2025 as against Rs 152.47 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 39.06 | 41.40 | -6 | 145.86 | 152.47 | -4 |
| OPM % | 7.96 | 6.98 | - | 7.66 | 7.29 | - |
| PBDT | 3.32 | 2.73 | 22 | 11.19 | 12.35 | -9 |
| PBT | 3.10 | 1.46 | 112 | 6.30 | 7.35 | -14 |
| NP | 1.31 | 1.46 | -10 | 4.15 | 7.35 | -44 |